Literature DB >> 22815045

Atrogin-1, MuRF-1, and sarcopenia.

Jonathan P Gumucio1, Christopher L Mendias.   

Abstract

Sarcopenia is one of the leading causes of disability in the elderly. Despite the growing prevalence of sarcopenia, the molecular mechanisms that control aging-related changes in muscle mass are not fully understood. The ubiquitin proteasome system is one of the major pathways that regulate muscle protein degradation, and this system plays a central role in controlling muscle size. Atrogin-1 and MuRF-1 are two E3 ubiquitin ligases that are important regulators of ubiquitin-mediated protein degradation in skeletal muscle. In this review, we will discuss: (i) aging-related changes to skeletal muscle structure and function; (ii) the regulation of protein synthesis and protein degradation by IGF-1, TGF-β, and myostatin, with emphasis on the control of atrogin-1 and MuRF-1 expression; and (iii) the potential for modulating atrogin-1 and MuRF-1 expression to treat or prevent sarcopenia.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22815045      PMCID: PMC3586538          DOI: 10.1007/s12020-012-9751-7

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  115 in total

Review 1.  The mitochondrial-lysosomal axis theory of aging: accumulation of damaged mitochondria as a result of imperfect autophagocytosis.

Authors:  Ulf T Brunk; Alexei Terman
Journal:  Eur J Biochem       Date:  2002-04

2.  Atrophy-related ubiquitin ligases, atrogin-1 and MuRF1 are up-regulated in aged rat Tibialis Anterior muscle.

Authors:  Stephan Clavel; Anne-Sophie Coldefy; Emilie Kurkdjian; Jérôme Salles; Irène Margaritis; Benoît Derijard
Journal:  Mech Ageing Dev       Date:  2006-09-01       Impact factor: 5.432

Review 3.  Cellular mechanisms regulating protein synthesis and skeletal muscle hypertrophy in animals.

Authors:  Mitsunori Miyazaki; Karyn A Esser
Journal:  J Appl Physiol (1985)       Date:  2008-11-26

4.  Antibody-directed myostatin inhibition in 21-mo-old mice reveals novel roles for myostatin signaling in skeletal muscle structure and function.

Authors:  Kate T Murphy; René Koopman; Timur Naim; Bertrand Léger; Jennifer Trieu; Chikwendu Ibebunjo; Gordon S Lynch
Journal:  FASEB J       Date:  2010-07-12       Impact factor: 5.191

5.  Decreased specific force and power production of muscle fibers from myostatin-deficient mice are associated with a suppression of protein degradation.

Authors:  Christopher L Mendias; Erdan Kayupov; Joshua R Bradley; Susan V Brooks; Dennis R Claflin
Journal:  J Appl Physiol (1985)       Date:  2011-05-12

6.  Development of a new patient-reported outcome measure in sarcopenia.

Authors:  Christopher J Evans; Chiun-Fang Chiou; Kristina A Fitzgerald; William J Evans; Betty R Ferrell; William Dale; Linda P Fried; Shravanthi R Gandra; Brooke Dennee-Sommers; Donald L Patrick
Journal:  J Am Med Dir Assoc       Date:  2010-11-25       Impact factor: 4.669

7.  TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle.

Authors:  Yi-Ping Li; Yuling Chen; Joseph John; Jennifer Moylan; Bingwen Jin; Douglas L Mann; Michael B Reid
Journal:  FASEB J       Date:  2005-03       Impact factor: 5.191

8.  The healthcare costs of sarcopenia in the United States.

Authors:  Ian Janssen; Donald S Shepard; Peter T Katzmarzyk; Ronenn Roubenoff
Journal:  J Am Geriatr Soc       Date:  2004-01       Impact factor: 5.562

9.  Satellite cells and myonuclei in young and elderly women and men.

Authors:  Fawzi Kadi; Nadia Charifi; Christian Denis; Jan Lexell
Journal:  Muscle Nerve       Date:  2004-01       Impact factor: 3.217

Review 10.  Multiple pathways to the same end: mechanisms of myonuclear apoptosis in sarcopenia of aging.

Authors:  Emanuele Marzetti; Giuseppe Privitera; Vincenzo Simili; Stephanie E Wohlgemuth; Lorenzo Aulisa; Marco Pahor; Christiaan Leeuwenburgh
Journal:  ScientificWorldJournal       Date:  2010-02-19
View more
  113 in total

1.  The TWEAK-Fn14 dyad is involved in age-associated pathological changes in skeletal muscle.

Authors:  Marjan M Tajrishi; Shuichi Sato; Jonghyun Shin; Timothy S Zheng; Linda C Burkly; Ashok Kumar
Journal:  Biochem Biophys Res Commun       Date:  2014-03-26       Impact factor: 3.575

Review 2.  Muscle-bone interactions: basic and clinical aspects.

Authors:  Luisella Cianferotti; Maria Luisa Brandi
Journal:  Endocrine       Date:  2013-08-29       Impact factor: 3.633

3.  Protective Effects of Ghrelin on Fasting-Induced Muscle Atrophy in Aging Mice.

Authors:  Chia-Shan Wu; Qiong Wei; Hongying Wang; Da Mi Kim; Miriam Balderas; Guoyao Wu; John Lawler; Stephen Safe; Shaodong Guo; Sridevi Devaraj; Zheng Chen; Yuxiang Sun
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-03-09       Impact factor: 6.053

4.  Changes in skeletal muscle and tendon structure and function following genetic inactivation of myostatin in rats.

Authors:  Christopher L Mendias; Evan B Lynch; Jonathan P Gumucio; Michael D Flood; Danielle S Rittman; Douglas W Van Pelt; Stuart M Roche; Carol S Davis
Journal:  J Physiol       Date:  2015-02-25       Impact factor: 5.182

Review 5.  Dietary protein and exercise for preservation of lean mass and perspectives on type 2 diabetes prevention.

Authors:  Maysa Vieira de Sousa; Diana Bento da Silva Soares; Elaine Reis Caraça; Ronaldo Cardoso
Journal:  Exp Biol Med (Maywood)       Date:  2019-07-15

6.  Optimizing mechanical stretching protocols for hypertrophic and anti-apoptotic responses in cardiomyocyte-like H9C2 cells.

Authors:  Evangelos Zevolis; Anastassios Philippou; Athanasios Moustogiannis; Antonios Chatzigeorgiou; Michael Koutsilieris
Journal:  Mol Biol Rep       Date:  2021-01-04       Impact factor: 2.316

7.  Characterization of Optimal Strain, Frequency and Duration of Mechanical Loading on Skeletal Myotubes' Biological Responses.

Authors:  Athanasios Moustogiannis; Anastassios Philippou; Evangelos Zevolis; Orjona Taso; Antonios Chatzigeorgiou; Michael Koutsilieris
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

8.  Different effects of the deletion of angiotensin converting enzyme 2 and chronic activation of the renin-angiotensin system on muscle weakness in middle-aged mice.

Authors:  Hikari Takeshita; Koichi Yamamoto; Masaki Mogi; Satoko Nozato; Masatsugu Horiuchi; Hiromi Rakugi
Journal:  Hypertens Res       Date:  2019-12-19       Impact factor: 3.872

Review 9.  FOXO transcription factors: key regulators of cellular quality control.

Authors:  Ashley E Webb; Anne Brunet
Journal:  Trends Biochem Sci       Date:  2014-03-13       Impact factor: 13.807

10.  Mouse forepaw lumbrical muscles are resistant to age-related declines in force production.

Authors:  Katelyn A Russell; Rainer Ng; John A Faulkner; Dennis R Claflin; Christopher L Mendias
Journal:  Exp Gerontol       Date:  2015-03-08       Impact factor: 4.032

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.